Stocks Bayer AG

More

  • Merck& Co. posted an 87 percent drop in fourth-quarter profit compared with last year when the drugmaker had a huge gain from the sale of consumer health business. It beat Wall Street profit forecasts, but came up short on revenue. "This is not business as usual, not in the U.S. and not globally," said analyst Steve Brozak, president of WBB Securities, adding, "Merck gets it."

  • NEW YORK, Dec 23- A new class of blood thinners that competes with widely used warfarin should get a boost next year when an "antidote" that can reverse the medications' effects in an emergency is expected to enter the market, according to top U.S. heart doctors and investors. Xarelto, from Bayer AG and Johnson& Johnson, and Eliquis, sold by Bristol-Myers Squibb and...

  • *Dow, Du Pont to merge, then split into three. Dec 11- Chemical titans DuPont and Dow Chemical Co agreed to combine in an all-stock merger valued at $130 billion in a move that pleased activist investors, would generate tax savings and trigger more consolidation while drawing scrutiny from regulators. The "deal of three centuries," as Wells Fargo analyst Frank Mitsch...

  • *Companies to merge, then split into three. Dec 11- Chemical titans DuPont and Dow Chemical Co agreed to combine in an all-stock merger valued at $130 billion in a move that pleased activist investors, would generate tax savings and trigger more consolidation while drawing scrutiny from regulators. The "deal of three centuries," as Wells Fargo analyst Frank Mitsch...

  • *Companies to merge, then split up into three. Dec 11- Chemical titans DuPont and Dow Chemical Co agreed to combine in an all-stock merger valued at $130 billion, a move that could trigger more consolidation, please activist investors and generate tax savings while drawing scrutiny from regulators. The "deal of three centuries," as Wells Fargo analyst Frank Mitsch...

  • Dec 9- A potential $130 billion merger of Dow Chemical Co and DuPont could prompt a renewed flurry of takeover bids for European rivals with Switzerland's Syngenta AG the most likely target. Syngenta, the world's largest agrochemicals company, fended off a $47 billion offer from U.S. group Monsanto in August and reportedly rejected a $42 billion pursuit by...

  • Europe stocks end under pressure; commodities, oil eyed Wednesday, 9 Dec 2015 | 11:56 AM ET
    Day laborers load coal into trucks at an open pit coal mine in the Bestacolla Colliery in Jharia, Jharkhand, India.

    European markets ended mixed to slightly lower on Wednesday as investors tried to digest what was happening with commodities.

  • With an era of cheap government farm credit ending as Brazil tries to curb runaway spending, farmers are seeking different ways to pay for fertilizer and equipment, potentially doubling the share of barter-based financing to 40 percent of the cost of the nation's crops, the most in at least a decade. For merchants, such as Cargill and CHS Inc, the largest U.S....

  • With an era of cheap government farm credit ending as Brazil tries to curb runaway spending, farmers are seeking different ways to pay for fertilizer and equipment, potentially doubling the share of barter-based financing to 40 percent of the cost of the nation's crops, the most in at least a decade. For merchants, such as Cargill and CHS Inc, the largest U.S....

  • Oct 16- Cempra Inc stock plunged 37 percent on Friday over potential safety concerns related to the company's drug to treat a common bacterial infection that met its main goal in a late-stage study. Patients in the second late-stage trial initially received IV administration of either solithromycin or Bayer AG's moxifloxacin, following which they could...

  • Oct 16- Cempra Inc moved a step closer to approval of its lead antibiotic after the potential blockbuster was successful in a second late-stage trial in patients with a common bacterial infection. Patients in this trial initially received IV administration of either solithromycin or Bayer AG's moxifloxacin, following which they could switch over to the...

  • At least half a dozen drugs, including colon cancer treatments Cyramza, from Eli Lilly& Co, and Stivarga, sold by Bayer AG, aren't worth prices that can exceed $100,000 a year, top cancer specialists said in interviews with Reuters. If specialists do start considering a drug's cost in their prescribing habits, such decisions could dent the multibillion-dollar...

  • Europe ends mixed; Tullow Oil soars; Altice sinks Thursday, 1 Oct 2015 | 11:30 AM ET

    European stocks closed mixed to lower on Thursday, as start-of-quarter enthusiasm petered out among investors and telecom stocks weighed on investor sentiment.

  • Sept 28- Bayer AG prevailed in a lawsuit filed by the U.S. Federal Trade Commission that accused the drugmaker's U.S. unit of making unsubstantiated claims about a dietary supplement marketed to promote digestion. District Judge Jose Linares in Newark, New Jersey refused to hold Bayer Corp in contempt for having allegedly violated a 2007 consent decree...

  • Sept 28- Bayer AG prevailed in a lawsuit filed by the U.S. Federal Trade Commission that accused the drugmaker's U.S. unit of making unsubstantiated claims about a dietary supplement marketed to promote digestion. District Judge Jose Linares in Newark, New Jersey refused to hold Bayer Corp in contempt for having allegedly violated a 2007 consent decree...

  • Sept 25- The first electronic automatic injector to deliver a drug for the most common form of multiple sclerosis received approval from the U.S. Food and Drug Administration on Friday. The new device, called Betaconnect, will be available in early 2016, said Germany's Bayer AG, which developed the injector and sells the drug. Although a sizable share of the MS...

  • WASHINGTON, Sept 22- U.S. health experts will review the potential risks of Bayer AG's permanent contraceptive device, Essure, on Thursday in light of growing complaints over possible side effects, and consider whether its use should be restricted. Some 17,000 women who had the device implanted and claim it has hurt them are members of the Facebook group "Essure...

  • Chipotle sued over GMO-free menu claims Tuesday, 1 Sep 2015 | 8:19 AM ET
    A Chipotle restaurant in New York.

    Chipotle Mexican Grill's new GMO-free menu claims have lured diners, but it has some consumers crying foul.

  • Chipotle sued over GMO-free menu claims Monday, 31 Aug 2015 | 5:05 PM ET

    Aug 31- Chipotle Mexican Grill Inc's new GMO-free menu claims have lured diners and boosted the burrito chain's stock price, but it has some consumers crying foul. A California woman has accused the popular chain in a lawsuit of false advertising after it trumpeted on April 27 that it was the first national restaurant company to use only ingredients that are...

  • Europe ends higher after bumper earnings day Wednesday, 29 Jul 2015 | 11:30 AM ET
    Federal Reserve building in Washington, D.C., U.S.

    European stocks finished higher on Wednesday after a bumper day of earnings, while investors awaited news from a two-day policy meeting of the U.S. Federal Reserve.